The meta-analysis demonstrated that the mRNA level of ANGPT2 was dramatically higher in ADC patients with lymph node metastasis (OR=1.58, 95% CI: 1.18-2.12, P=0.524, and I2=0.0%) (Figure 5E). The gene discussed is ANGPT2; the disease is metastatic malignant neoplasm in the lymph nodes.